Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

3-(1,2,3,4-Tetrahydro-1-Naphthyl)-4-Hydroxycoumarin

    • Product Name 3-(1,2,3,4-Tetrahydro-1-Naphthyl)-4-Hydroxycoumarin
    • Alias NADICOL
    • Einecs 249-101-5
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    227581

    Iupac Name 3-(1,2,3,4-Tetrahydronaphthalen-1-yl)-4-hydroxy-2H-chromen-2-one
    Molecular Formula C19H16O3
    Molecular Weight 292.33 g/mol
    Cas Number 23569-56-0
    Appearance White to off-white crystalline powder
    Melting Point 163-165 °C
    Solubility Sparingly soluble in water, soluble in organic solvents
    Synonyms Tetrindole-4-hydroxycoumarin, 3-(1,2,3,4-Tetrahydronaphthalen-1-yl)-4-hydroxycoumarin
    Chemical Class 4-Hydroxycoumarin derivative
    Structure Type Polycyclic aromatic with coumarin core
    Logp Estimated 4.2
    Storage Conditions Store at room temperature, protect from light
    Hazard Statements May be harmful if swallowed or inhaled

    As an accredited 3-(1,2,3,4-Tetrahydro-1-Naphthyl)-4-Hydroxycoumarin factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Amber glass bottle containing 25 grams of 3-(1,2,3,4-Tetrahydro-1-Naphthyl)-4-Hydroxycoumarin, labeled with product details and safety information.
    Shipping The chemical **3-(1,2,3,4-Tetrahydro-1-Naphthyl)-4-Hydroxycoumarin** is shipped in tightly sealed, inert containers to prevent contamination or degradation. It is packaged according to regulations for laboratory chemicals, with proper labeling and documentation. Shipping is conducted under temperature-controlled conditions if required, and includes all relevant safety and hazard information.
    Storage Store 3-(1,2,3,4-Tetrahydro-1-Naphthyl)-4-Hydroxycoumarin in a tightly sealed container, protected from light and moisture, in a cool, dry, and well-ventilated area. Keep away from incompatible substances such as strong oxidizers. The storage area should be clearly labeled and restricted to authorized personnel. Handle using appropriate protective equipment to prevent inhalation and skin contact.
    Application of 3-(1,2,3,4-Tetrahydro-1-Naphthyl)-4-Hydroxycoumarin

    Applications of 3-(1,2,3,4-Tetrahydro-1-Naphthyl)-4-Hydroxycoumarin in Industrial Manufacturing

    As a direct manufacturer of 3-(1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin, we have established supply partnerships with industrial formulators and downstream producers requiring advanced coumarin derivatives for regulated end-uses. The following application sectors and integration details reflect real industrial adoption, supported by current quality system and regulatory practice.

    1. Anticoagulant Active Pharma Ingredient (API) Production

    Pharmaceutical companies utilize this coumarin derivative primarily for synthesizing anticoagulant APIs, leveraging its functional motif which confers vitamin K antagonism central to finished drug activity. The integration process involves precise stoichiometric addition in multi-step active pharmaceutical ingredient synthesis, forming the backbone of oral anticoagulant drugs for chronic cardiovascular management.

    Industry compliance standards

    • USP/NF Monograph requirements for anticoagulant APIs
    • WHO Good Manufacturing Practice (GMP) for pharmaceutical substances
    • ICH Q7: Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • FDA 21 CFR Part 210/211 for finished pharmaceutical products

    Typical usage ratio

    • Integrated at 0.08%–0.16% w/w per batch, tuned by target molecular conversion and purity profile; ratio adjusted based on reaction yield and downstream purification constraints

    Downstream process integration

    • Introduced during intermediate synthesis, followed by condensation and selective reduction steps; purified using crystallization before final formulation

    Final product types

    • Prescription solid oral anticoagulant tablets
    • Bulk active pharmaceutical ingredient for export
    • Blood thinner raw material blends in contract manufacturing operations

    2. Rodenticide Technical Formulations

    Specialty chemicals producers employ 3-(1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin as a key technical agent in second-generation anti-coagulant rodenticide concentrates. This application requires careful alignment with established safety controls and environmental regulations, since persistent residues must remain within regulated toxicological limits in grain bait and pellet formats.

    Industry compliance standards

    • EU Biocidal Products Regulation (BPR, Regulation (EU) 528/2012)
    • US EPA Product Performance Test Guidelines OPPTS 810.2000
    • China GB 20784-2006: National food rodenticide production standard
    • FAO/WHO Guidelines on Household Use of Rodenticides

    Typical usage ratio

    • Blended at 0.003%–0.005% w/w in finished rodenticide formulations, adjusted based on target lethality and substrate type in manufacturing lines

    Downstream process integration

    • Dispersed into aqueous or oily carrier bases during the concentrate mixing stage, followed by granulation, compaction, and post-treatment stabilization

    Final product types

    • Ready-to-use grain bait packs for urban pest control
    • Pelletized outdoor rodent bait stations
    • Technical concentrates for agricultural rodent protection

    3. Livestock Premix & Veterinary Formulations

    Animal health manufacturers depend on the precision blending of coumarin-type derivatives into veterinary premixes for controlled anticoagulation therapies in livestock. This application focuses on traceability and controlled dosage protocols to prevent toxicity, utilizing regulated inclusion rates and batch record requirements for medicated feed additive registration.

    Industry compliance standards

    • EU Feed Additives Register (Regulation (EC) No 1831/2003)
    • US FDA Center for Veterinary Medicine (CVM) Guidance for Industry #120
    • Chinese Veterinary Pharmacopoeia Standards (2020 Edition)
    • ISO 22000: Food Safety Management System for feed manufacturing

    Typical usage ratio

    • Incorporated at 0.0005%–0.001% by weight of complete feed, strictly based on veterinary prescription and animal weight; batch mixing logs ensure compliance

    Downstream process integration

    • Dosed at the micro-ingredient addition stage with homogeneous blending into feed premixes, followed by granulation or pelleting before pack-off

    Final product types

    • Powder and granular medicated animal feed supplements
    • Livestock oral drench concentrates for farm veterinary application
    • Bulk veterinary technical grade additives for compounding

    4. Research Reagents for Blood Coagulation Studies

    Research and diagnostic reagent manufacturers incorporate this compound into validated in-vitro laboratory kits for anticoagulant screening and blood coagulation pathway studies. This scenario requires analytical traceability and reproducibility at controlled concentrations, supporting accredited laboratory testing in clinical, university, and industrial R&D applications.

    Industry compliance standards

    • ISO 13485: Medical Devices Quality Management for diagnostic reagent production
    • CLSI EP25-A: Evaluation of Stability of In Vitro Diagnostic Reagents
    • OECD Principles of Good Laboratory Practice (GLP)
    • EN ISO 15189: Accreditation of medical laboratories

    Typical usage ratio

    • Prepared at 0.01%–0.05% w/v in plasma or buffer systems, dependent on required sensitivity for anti-coagulant response curves and laboratory protocol specifics

    Downstream process integration

    • Added during analytic reagent formulation and buffer preparation; sterile filtration and aliquoting conducted under QC-monitored environments

    Final product types

    • In-vitro diagnostic assay kits for coagulation testing
    • Reference reagent solutions for laboratory research
    • Blood plasma stability analysis kits for clinical R&D
    Free Quote

    Competitive 3-(1,2,3,4-Tetrahydro-1-Naphthyl)-4-Hydroxycoumarin prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    3-(1,2,3,4-Tetrahydro-1-Naphthyl)-4-Hydroxycoumarin: An Experienced Manufacturer’s Perspective

    Looking at the Compound from Production to Application

    In our years producing 3-(1,2,3,4-Tetrahydro-1-Naphthyl)-4-Hydroxycoumarin, we have learned that precision at every stage—synthesis, purification, tailoring crystal morphology, even packaging—strengthens quality. We follow a defined process from raw material screening through final batch QC, reviewing every output. The naphthyl group’s tetrahydro configuration creates a compound quite distinct from traditional coumarin derivatives. Our team treats each step with respect for both the molecule’s reactive features and the high performance standards expected by formulators.

    Quality Standards Come from the Workbench, Not a Catalog

    Producing this molecule at large scale introduces constant hurdles. Each batch, no matter the volume, must be tested beyond generic benchmarks. The hydroxycoumarin backbone can pick up minute impurities that alter solubility or bioreactivity if left unchecked. So, we keep instruments tuned and demand standards above industry “minimum pass” marks. From HPLC purity readings to drying curves and glass transition observations, long-term experience shapes how we assure repeatability. We encounter requests for various particle size profiles and will adjust synthesis or milling steps to get exact specifications. This results from listening to feedback and understanding downstream processing, not just relying on supplier recommendations.

    Molecular Structure and Why It Determines Usefulness

    The way tetrahydronaphthyl groups interact with hydroxycoumarin rings influences this compound’s physical properties, stability under light and air, and compatibility with a broad set of co-ingredients. This unique structure drives its value in anticoagulant agents, biochemical research, and intermediate synthesis for further modification. We have run stress tests on exposure to various excipients, solvents, and pH conditions. Unlike straight-chain or unmodified coumarins, our product resists oxidative breakdown much more effectively.

    Product Models and Customization: Beyond a Standard SKU

    Over the years, we responded to direct customer feedback, not only providing a standard grade but also developing higher purity lines and alternative morphology options. Some service sectors favor a fine powder for suspension formulations, while others want coarse crystals for direct tablet pressing. Our technical team reviews every order specification, adjusting process parameters such as crystallization temperature or antisolvent selection. We never shortcut purification through speculative tweaks. Instead, we continuously experiment with process adjustments to see what results bring the highest consistency and batch-to-batch reproducibility over time.

    Comparing to Other Hydroxycoumarin Derivatives

    Many coumarin derivatives offer structural elegance but lack the stability required for high-precision use. Our 3-(1,2,3,4-Tetrahydro-1-Naphthyl) modification increases molecular rigidity and changes physicochemical properties in a way basic 4-hydroxycoumarins do not. In our process, we’ve seen less tendency toward degradation, even under repeated handling or exposure to UV. Labs working with standard 4-hydroxycoumarin often report short shelf life or unpredictable solubility. We decided long ago to monitor every metric around these pain points—so particle size distribution, stability data, and impurity profiles remain front and center. This focus has led to a form which researchers and formulating chemists handle with less loss and fewer compatibility issues downstream.

    The Realities of Production: Equipment, Teams, and the Human Element

    Any manufacturer can print a product specification from a textbook, but our best insights come from the shop floor. It starts with vetted supply chains for feedstock naphthalenes and solvents, followed by skilled reaction monitoring. Even minor inconsistencies in temperature control shift product ratios and have downstream effects. One heated vessel running two degrees higher can set us back days in recrystallization. Our operators double-check every valve setting and sample frequently to stay ahead of drift. Post-reaction, we put as much energy into purification—using column chromatography or multi-stage washing—as we do into the original synthesis. R&D and production teams meet every month to share results and catch blind spots.

    Meeting Analytical Demands and Documenting Every Stage

    Scientific end users expect full documentation, and for good reason. A physiochemical test suite covers melting point, loss on drying, heavy metal content, and specific impurity monitoring. The tetrahydro-1-naphthyl group complicates routine QC, since common assays can underreport some trace byproducts. We developed in-house reference standards and custom calibration curves using recognized international frameworks, such as ICH Q6A. This isn’t about ticking regulatory checklists— it’s about creating certainty for partners down the supply chain who depend on our transparency.

    Case Studies: Partnering for Custom Solutions

    Researchers and formulators frequently face the problem of poor compound dispersibility or aggregation in complex mixtures. During collaborative projects, we learned the importance of tailoring drying methods to suit end-use—vacuum tray drying for one customer, spray drying for another. When a formulation partner struggled with unexpected phase separation, our technical team ran controlled stability trials and helped adjust both our particle size and their mixing protocol. We saw that cutting corners—even shaving a few hours off drying—could change dispersibility, which in turn could affect activity in bioassays. Applying firsthand knowledge of how our molecules behave in real-world settings has led to product versions that go beyond a typical catalog entry.

    Addressing Sourcing Challenges and Market Uncertainties

    Commoditized chemical distributors often promise endless stock. From the manufacturer’s desk, raw material volatility and shipping disruptions never disappear. A few years back, a shipping hold-up forced us to recalibrate not just logistics but also inventory management. We inform clients, especially those running tight research timelines, about worst-case lead times. This transparency helps them plan, and it pushes us to maintain higher inventory of key intermediates. We learned to diversify supply chains and keep direct relationships with key upstream vendors. These practices, while increasing operating costs, provide more reliable access to quality product for those who refuse to accept mediocrity.

    Why End-Use Experience Matters: Hearing from the Lab

    Real insight comes from those who actually formulate, dose, or modify this compound. We support partners who feed data back to us on performance. When a team saw a drift in assay response related to ambient humidity, our own QC chemists replicated the conditions and isolated the variable. These details inform tweaks that make each new batch more stable season after season. Direct relationships with downstream users amplify our understanding of nuanced technical challenges and give us a foundation for more robust quality improvement.

    Adapting to Increasing Regulatory Scrutiny

    The global chemical landscape faces tightening regulatory oversight, especially for compounds used as pharmaceutical intermediates or in specialty crop protection. We engage with evolving standards—not just for the sake of compliance, but because unchecked impurities or handling risks sabotage years of R&D progress. Recent EU regulations required us to re-examine process solvents and requalify residual profiles. Rather than waiting for external audits to prompt change, our compliance desk works ahead of the regulatory curve. We produce regular reviews of REACH and US EPA updates and invest in in-house training so every technician knows what’s at stake. It’s not the least costly approach, but it’s the one that lets us keep customer trust long term.

    Environmental Responsibility at the Production Level

    Waste minimization takes center stage. Not just because regulators care—although they do—but because solvent recovery and effluent pre-treatment safeguard future operations from unnecessary shutdowns. We engineered multi-stage solvent recovery loops so acetonitrile and THF recycling decreased new purchase volumes. Our water treatment plant removes chlorinated organic traces well below national thresholds. These investments don’t attract instant praise, but they let us operate with a cleaner conscience. It’s not always an easy sell internally, but the long-term competitive advantage grows as environmental reporting requirements become stricter worldwide.

    Equipment Upgrades: Investing for Precision

    Older equipment often brings hidden variability to final product quality, whether through cross-contamination, worn seals, or reaction vessel scaling. Over the past several years, we allocated funds not only for new reactors and filtrations systems but also for digital monitoring and feedback control systems. This data-centric production gives us tighter control over reaction endpoints and batch traceability. When upgrades slow output for a week, we prioritize validation of new systems in partnership with production, not just IT. Over time, this reduces operator error and increases confidence in every lot shipped.

    Challenges in Workforce Development

    Chemistry remains a field where rote training only goes so far. Our best results came from investing in flexible training that exposes junior staff to both synthesis and QC. We developed a mentoring system where production leads teach hands-on troubleshooting—from glassware assembly to real-time process adjustments based on sample readings. This helps bridge the gap between academic chemical training and the realities of industrial-scale synthesis, reducing onboarding time and increasing team-wide expertise.

    Cost Pressures and Product Value

    Market demand for high-purity specialty molecules appears cyclical, but firms treating these as commodities tend to ignore true cost drivers—deviation management, repeat analysis, regulatory reporting, and waste reduction. Our price advantages come less from chasing the cheapest feedstocks and more from optimizing every step, reducing rework, and ensuring long-run stability. Clients who compare purely on price often experience run-ins with inconsistent supply or hidden impurity profiles. Transparent communication about what goes into each order changes the value equation and builds long-term confidence.

    The Role of Data in Continuous Process Improvement

    Over years of production, we accumulated detailed dataset on yields, impurity patterns, equipment performance, and customer feedback. We conduct frequent trend analyses, using both operator notes and digital logs. If a seemingly minor shift in precipitation temperature links to a higher incidence of filtration problems, we trace it back and update our standard operating procedures. Our best process changes came from connecting data across several disciplines—synthesis, purification, and even last-mile packaging.

    Collaborative Innovation: Partnering with Downstream Users

    Innovation doesn’t come from siloed R&D. We frequently open our labs to pilot studies with partner organizations, allowing them to run test batches in our equipment. This direct collaboration accelerates feedback and highlights process nuances that wouldn’t surface in off-site trials. By working side-by-side, our chemists gain new perspectives into ultimate application requirements, leading to iterations that better align with both the scientific and operational needs of end users.

    Product Security and Counterfeit Prevention

    As specialty chemicals gain value, reports of counterfeit or substandard versions rise. We respond with multi-level product tagging, batch-linked certifications and supplier audits. A clear paper trail, from kilogram drums to final application, underpins trust in the material’s authenticity. Where possible, we share data with key partners to jointly monitor supply chain integrity and identify at-risk points before issues arise. While these measures involve new technology and documentation costs, the assurance they grant to researchers and formulators far outweighs up-front investment.

    Supporting a Global User Base

    Supplying high-value chemical intermediates across continents involves tight customs compliance, multilingual documentation and familiarity with local quality requirements. Our technical support group works across time zones, providing application-specific guidance and troubleshooting. These hands-on partnerships have helped bridge knowledge gaps as regulations and market trends shift regionally. As researchers in one country push the boundaries of anticoagulant analogs while another group seeks process-friendly intermediates, we tune our product and service model to remain relevant.

    Lessons from Decades in Chemical Manufacturing

    Over years, product specifications changed, regulatory expectations shifted, but the fundamentals stayed the same: control every variable—human or technical—and stay close to users’ real-world needs. We have seen new users train on our compound for the first time and seasoned formulators modify old methods based on a new batch’s subtle behavior. The signals are often subtle—slower filtration, a change in color, an unusual result in a stability assay. By focusing on technical accuracy, user collaboration and real-world feedback, we continue to build a product line that sets a higher standard for both performance and reliability in chemical manufacturing.

    Final Thoughts on 3-(1,2,3,4-Tetrahydro-1-Naphthyl)-4-Hydroxycoumarin as a Specialty Compound

    Serving research, pharmaceutical, and technical markets with this compound shapes our daily routines, decisions, and investments. Unlike short-lived ordering relationships, we’ve learned to grow through candid conversations about both failures and successes. Years of incremental improvements, from pilot batch to scaled production, force us to ask not only “How pure?” but “How useful in the field?” We focus on making every shipment a tool researchers can count on, not just a line item on an invoice. It’s these principles—rooted in experience, honest problem-solving, and attention to detail—that let a specialty chemical like 3-(1,2,3,4-Tetrahydro-1-Naphthyl)-4-Hydroxycoumarin deliver meaningful results in the lab and beyond.